Login / Signup

Sensitive quantitative IgD assay increases progression-free survival prediction accuracy in IgD plasma cell myeloma.

Jin LiuJing LuWanting QiangYanchun JiaHaiyan HeXiaofei YeWee-Joo ChngRobert Peter GaleZhi-Wei LiangJian HouJuan Du
Published in: Leukemia (2022)
Keyphrases
  • free survival
  • single cell
  • high throughput
  • cell therapy
  • multiple myeloma
  • high resolution
  • newly diagnosed
  • stem cells